Tudóstér: Sturniolo Isotta publikációi

Sturniolo, I., Váróczy, C., Regdon, Z., Türk-Mázló, A., Muzsai, S., Bácsi, A., Intili, G., Hegedűs, C., Boothby, M., Holechek, J., Ferraris, D., Schüler, H., Virág, L.: PARP14 contributes to the development of the tumor-associated macrophage phenotype.
Int. J. Mol. Sci. 25 (7), 1-21, 2024.

Sturniolo, I., Váróczy, C., Bede, Á., Hegedűs, C., Demény, M., Virág, L.: Quantifying antibody-dependent cellular cytotoxicity in a tumor spheroid model: application for drug discovery.
J. Vis. Exp. [Epub ahead of print]2024.

Guti, E., Regdon, Z., Sturniolo, I., Kiss, A., Kovács, K., Demény, M., Szöőr, Á., Vereb, G., Szöllősi, J., Hegedűs, C., Polgár, Z., Virág, L.: The multitargeted receptor tyrosine kinase inhibitor sunitinib induces resistance of HER2 positive breast cancer cells to trastuzumab-mediated ADCC.
Cancer Immunol. Immunother. 71 (9), 2151-2168, 2022.

Kiss, A., Ráduly, A., Regdon, Z., Polgár, Z., Tarapcsák, S., Sturniolo, I., El-Hamoly, T., Virág, L., Hegedűs, C.: Targeting nuclear NAD+ synthesis inhibits DNA repair, impairs metabolic adaptation increases chemosensitivity of U-2OS osteosarcoma cells.
Cancers (Basel). 12 (5), 1-27, 2020.

Kumar, J., Murugaiah, V., Sotiriadis, G., Kaur, A., Jeyaneethi, J., Sturniolo, I., Alhamlan, F., Chatterjee, J., Hall, M., Kishore, U., Karteris, E.: Surfactant Protein D as a Potential Biomarker and Therapeutic Target in Ovarian Cancer.
Front Oncol. 9 1-14, 2019.